Patents by Inventor John H. E. J. Martin

John H. E. J. Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biologically pure culture of Streptoverticillium stramineum sp. nov.
    Patent number: 4650765
    Abstract: This invention relates to two new antibacterial and anti-tumor agents designated LL-BO1208.alpha. and LL-BO1208.beta. produced during microbiological fermentation, under controlled conditions, using the novel microorganism Streptoverticillium stramineum and mutants thereof.
    Type: Grant
    Filed: July 30, 1985
    Date of Patent: March 17, 1987
    Assignee: American Cyanamid Company
    Inventors: Jane P. Kirby, Amedeo A. Fantini, Donald B. Borders, Raymond T. Testa, John H. E. J. Martin, deceased
  • Antibiotic LL-C23201.delta.
    Patent number: 4628046
    Abstract: This disclosure describes a new antibacterial agent designated LL-C23201.delta., produced in a microbiological fermentation under controlled conditions using a new strain of Streptomyces olivaceo-griseus, sp. nov. and mutants thereof. This new antibacterial agent is active against a variety of microorganisms and thus is useful in inhibiting the growth of such bacteria wherever they may be found.
    Type: Grant
    Filed: June 20, 1983
    Date of Patent: December 9, 1986
    Assignee: American Cyanamid Company
    Inventors: David P. Labeda, Joseph J. Goodman, John H. E. J. Martin, deceased
  • Biologically pure culture of Streptomyces majorciensis Labeda
    Patent number: 4608343
    Abstract: This disclosure describes four new antibacterial agents designated LL-C08078.alpha..sub.1, LL-C08078.alpha..sub.2, LL-C08078.alpha..sub.3 and LL-C08078.beta. produced in a microbiological fermentation under controlled conditions using a new strain of a new species of the genus Streptomyces called Streptomyces majorciensis Labeda, sp. nov., and mutants thereof. These new antibacterial agents are active against a variety of microorganisms and thus are useful in inhibiting the growth of such bacteria wherever they may be found. In addition, these agents are active as growth promotants in warm-blooded animals.
    Type: Grant
    Filed: May 30, 1985
    Date of Patent: August 26, 1986
    Assignee: American Cyanamid Company
    Inventors: David P. Labeda, Joseph J. Goodman, Donald B. Borders, Raymond T. Testa, John H. E. J. Martin, deceased
  • Antibiotic LL-BO1208.alpha. and LL-BO1208.beta., process of preparation, pharmaceutical composition and method of use
    Patent number: 4552867
    Abstract: This invention relates to two new antibacterial and anti-tumor agents designated LL-BO1208.alpha. and LL-BO1208.beta. produced during microbiological fermentation, under controlled conditions, using the novel microorganism Streptoverticillium stramineum and mutants thereof.
    Type: Grant
    Filed: July 5, 1983
    Date of Patent: November 12, 1985
    Assignee: American Cyanamid Company
    Inventors: John H. E. J. Martin, Jane P. Kirby, Donald B. Borders, Amedeo A. Fantini, Raymond T. Testa
  • Antibacterial antibiotics LL-CO8078.alpha..sub.1, .alpha..sub.2, .alpha..sub.3 and .beta.
    Patent number: 4534970
    Abstract: This disclosure describes four new antibacterial agents designated LL-CO8078.alpha..sub.1, LL-CO8078.alpha..sub.2, LL-CO8078.alpha..sub.3 and LL-CO8078.beta. produced in a microbiological fermentation under controlled conditions using a new strain of a new species of the genus Streptomyces called Streptomyces majorciensis Labeda, sp. nov., and mutants thereof. These new antibacterial agents are active against a variety of microorganisms and thus are useful in inhibiting the growth of such bacteria wherever they may be found. In addition, these agents are active as growth promotants in warm-blooded animals.
    Type: Grant
    Filed: June 23, 1983
    Date of Patent: August 13, 1985
    Assignee: American Cyanamid Company
    Inventors: David P. Labeda, Joseph J. Goodman, Donald B. Borders, Raymond T. Testa, John H. E. J. Martin, deceased
  • Process for producing antibiotic X-14868A
    Patent number: 4407946
    Abstract: This invention relates to a novel process for the production of antibiotic X-14868A using the novel microorganism Antinomadura yumaense sp. nov.
    Type: Grant
    Filed: October 22, 1981
    Date of Patent: October 4, 1983
    Assignee: American Cyanamid Company
    Inventors: David P. Labeda, John H. E. J. Martin, Joseph J. Goodman
  • Process for producing the antibiotic nosiheptide
    Patent number: 4384043
    Abstract: This disclosure describes a novel process for the production of the known antibiotic nosiheptide using a new strain of Streptomyces glaucogriseus and mutants thereof.
    Type: Grant
    Filed: September 2, 1981
    Date of Patent: May 17, 1983
    Assignee: American Cyanamid Company
    Inventors: John H. E. J. Martin, David P. Labeda, Joseph D. Korshalla, Donald B. Borders, Raymond T. Testa
  • Process of producing antibiotic BL580.DELTA. with Streptomyces hygroscopicus
    Patent number: 4189537
    Abstract: This disclosure describes a new antibiotic designated BL580.DELTA. produced in a microbiological fermentation under controlled conditions using a new strain of Streptomyces hygroscopicus and mutants thereof. This new antibiotic is an active anticoccidial agent.
    Type: Grant
    Filed: November 20, 1978
    Date of Patent: February 19, 1980
    Assignee: American Cyanamid Company
    Inventors: John H. E. J. Martin, Martin R. Hertz
  • Antibiotic BL580.DELTA. and method of use
    Patent number: 4138481
    Abstract: This disclosure describes a new antibiotic designated BL580.DELTA. produced in a microbiological fermentation under controlled conditions using a new strain of Streptomyces hygroscopicus and mutants thereof. This new antibiotic is an active anticoccidial agent.
    Type: Grant
    Filed: January 4, 1977
    Date of Patent: February 6, 1979
    Assignee: American Cyanamid Company
    Inventors: John H. E. J. Martin, Martin R. Hertz
  • Antibiotic BL580 Zeta and use thereof as anticoccidial agent
    Patent number: 4132779
    Abstract: This disclosure describes a new antibiotic designated BL580 ZETA produced in a microbiological fermentation under controlled conditions using a new strain of Streptomyces hygroscopicus and mutants thereof. This new antibiotic is an active anticoccidial agent.
    Type: Grant
    Filed: June 20, 1977
    Date of Patent: January 2, 1979
    Assignee: American Cyanamid Company
    Inventors: Martin R. Hertz, John H. E. J. Martin